Presoaked IOLs show dual action

Article

Intraocular lenses (IOLs) soaked in antibiotics have antimicrobial properties, according to results published in the October issue of the Journal of Ocular Pharmacology and Therapeutics.

Intraocular lenses (IOLs) soaked in antibiotics have antimicrobial properties, according to results published in the October issue of the Journal of Ocular Pharmacology and Therapeutics.

Edward F. Smith of the department of ophthalmology at the State University of New York (SUNY), US and colleagues immersed six groups (each group, n=8–10) of commercially available IOLs in fourth-generation fluoroquinolones as follows: 1.8 µg/mL moxifloxacin for 60 minutes; 5 mg/mL moxifloxacin for one minute; 5 mg/mL moxifloxacin for 60 minutes; 0.48 µg/mL gatifloxacin for 60 minutes; 3 mg/mL gatifloxacin for one minute; and 3 mg/mL gatifloxacin for 60 minutes. A control group of IOLs was soaked in saline for 60 minutes. The IOLs were placed in agar with an overlay of S. aureus and after 24 hours, the team measured bacterial kill zones.

Among the groups soaked in lower-strength doses of antibiotic for 60 minutes, the 0.48 µg/mL gatifloxacin and saline produced no measurable bacterial kill zone, whereas the 1.8 µg/mL moxifloxacin group produced a bacterial kill zone of 3.88±3.18 mm. A kill zone of ≥33 mm was achieved by all groups soaked in high dose fluoroquinolones: for the 5 mg/mL moxifloxacin group (one minute), this was 38.80±3.74 mm; 3 mg/mL gatifloxacin (one minute), 34.30±1.34 mm; 5 mg/mL moxifloxacin (60 minutes), 33.56±1.42 mm; 3 mg/mL gatifloxacin (60 minutes), 33.67±0.50 mm.

Thus the researchers concluded that soaking IOLs in high (commercial) levels of fluoroquinolones produces IOLs with antimicrobial properties in vitro. The widest bacterial kill zone was achieved with IOLs immersed for one minute in 5 mg/mL of moxifloxacin.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.